![Norman Ruchholtz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Norman Ruchholtz
Directeur Général chez Cantourage GmbH
Postes actifs de Norman Ruchholtz
Sociétés | Poste | Début | Fin |
---|---|---|---|
Cantourage GmbH
![]() Cantourage GmbH Pharmaceuticals: MajorHealth Technology Part of Cantourage Group SE, Cantourage GmbH is a leading European medical cannabis company based in Kleinmachnow, Germany. The German company focuses on long-term collaborations and strategic partnerships to provide patients with an unprecedented selection of the highest quality cannabis medicines at affordable prices. Cantourage offers products in all relevant market segments, including dried flowers, extracts, dronabinol, and pharma-grade cannabidiol. Cantourage's unique fast track access platform enables producers from across the world to become part of the rapidly growing European medical cannabis market, providing medical cannabis-related products to millions of people in Europe. The company was founded in 2019 by Florian Holzapfel, Patrick Hoffmann, and Norman Ruchholtz, who has been the CEO since 2019. | Directeur Général | 01/01/2019 | - |
Fondateur | 01/01/2019 | - |
Historique de carrière de Norman Ruchholtz
Anciens postes connus de Norman Ruchholtz
Sociétés | Poste | Début | Fin |
---|---|---|---|
CANTOURAGE GROUP SE | Fondateur | 01/01/2019 | - |
Statistiques
Internationale
Allemagne | 3 |
Opérationnelle
Founder | 2 |
Chief Executive Officer | 1 |
Sectorielle
Health Technology | 2 |
Process Industries | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
CANTOURAGE GROUP SE | Process Industries |
Entreprise privées | 1 |
---|---|
Cantourage GmbH
![]() Cantourage GmbH Pharmaceuticals: MajorHealth Technology Part of Cantourage Group SE, Cantourage GmbH is a leading European medical cannabis company based in Kleinmachnow, Germany. The German company focuses on long-term collaborations and strategic partnerships to provide patients with an unprecedented selection of the highest quality cannabis medicines at affordable prices. Cantourage offers products in all relevant market segments, including dried flowers, extracts, dronabinol, and pharma-grade cannabidiol. Cantourage's unique fast track access platform enables producers from across the world to become part of the rapidly growing European medical cannabis market, providing medical cannabis-related products to millions of people in Europe. The company was founded in 2019 by Florian Holzapfel, Patrick Hoffmann, and Norman Ruchholtz, who has been the CEO since 2019. | Health Technology |
- Bourse
- Insiders
- Norman Ruchholtz
- Expérience